22,736 results on '"Rivaroxaban"'
Search Results
2. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
3. Dabigatran for the Adjunctive Treatment of Staphylococcus Aureus Bacteremia (DABI-SNAP)
4. Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment (RITMUS-AF)
5. An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
6. Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism (COBRRA)
7. Comparison of Bleeding Risk Between Rivaroxaban and Apixaban (COBRRA Pilot)
8. COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation (COBRRA-AF)
9. A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) (XAPAEDUS)
10. A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF) (XARIN)
11. Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
12. Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants
13. Anticoagulation in Patients With Venous Thromboembolism and Cancer (VICTORIE)
14. Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke (ARCHIMEDES)
15. DEFIANCE: RCT of ClotTriever System Versus Anticoagulation in Deep Vein Thrombosis (DEFIANCE)
16. High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France (HELIOS-AF)
17. An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
18. Postoperative Thrombosis Prevention in Patients With CD (PIT-CD)
19. Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation (ERSAF)
20. ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty (ENABLE-Hip)
21. The Gynecological Cancer Associated Thrombosis (GynCAT) Study (GynCAT)
22. The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
23. Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
24. Observational Study:Safety,Efficacy and Quality of Life of Patients With Atrial Fibrillation, Treated With Trombix® (TROMBIXDZ)
25. Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
26. RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing (RIVACAST)
27. Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
28. Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
29. Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets
30. Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets
31. Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin
32. Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
33. Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy (REBIRTH)
34. Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
35. Thromboprophylaxis in Lower Limb Immobilisation (TiLLI)
36. Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation (SPIRIT)
37. Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) (REATTAIN)
38. Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)
39. Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant
40. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)
41. Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial (OCEAN)
42. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)
43. Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF (APERITIF)
44. Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease
45. Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement (RENOVATE)
46. Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)
47. Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
48. Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation (SPICAF)
49. Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
50. Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery (ASPIRE-AF)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.